Skip to content
healthcare.dev

CLE CCC Warm Deep

NDC 69231-032, Titanium Dioxide, Octinoxate, Octisalate, Avobenzone, cream, from KW ABSC, INC..

Product NDC
69231-032
Status
Listed
Labeler
KW ABSC, INC.
Dosage form
CREAM
Route
TOPICAL
Product type
HUMAN OTC DRUG
Marketing category
OTC MONOGRAPH DRUG
Application
M020
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/69231-032 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • OCTINOXATE2.1 mg/30mL
  • OCTISALATE.6 mg/30mL
  • TITANIUM DIOXIDE.51 mg/30mL
  • AVOBENZONE.156 mg/30mL
Package NDCNDC-11Package
69231-032-02692310032021 CONTAINER in 1 PACKAGE (69231-032-02) / 30 mL in 1 CONTAINER (69231-032-01)

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 69231-032 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/69231-032 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 69231-032. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.